Gennex Laboratories Ltd

Gennex Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gennex Laboratories Ltd

₹ 10.6 -2.48%
05 Jun - close price
gennexlab.com BSE: 531739
About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Key Points

Business Overview:[1][2]
GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants,
Muscle Relaxants, Analgesic and Anti Fungal, etc.

Website BSE
  • Market Cap ₹ 258 Cr.
  • Current Price ₹ 10.6
  • High / Low ₹ 17.2 / 7.05
  • Stock P/E 15.5
  • Book Value ₹ 8.98
  • Dividend Yield 0.00 %
  • ROCE 9.98 %
  • ROE 8.27 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Stock is trading at 1.18 times its book value
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 31.0% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 23.6%
  • Tax rate seems low
  • Company has a low return on equity of 8.46% over last 3 years.
  • Earnings include an other income of Rs.7.54 Cr.
  • Debtor days have increased from 73.9 to 102 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
18.15 14.14 14.24 19.32 21.33 21.33 26.51 27.35 23.28 25.64 31.37 30.72 36.71
16.88 10.22 10.27 15.64 18.24 18.41 20.98 21.78 23.06 22.26 25.38 24.57 33.53
Operating Profit 1.27 3.92 3.97 3.68 3.09 2.92 5.53 5.57 0.22 3.38 5.99 6.15 3.18
OPM % 7.00% 27.72% 27.88% 19.05% 14.49% 13.69% 20.86% 20.37% 0.95% 13.18% 19.09% 20.02% 8.66%
1.59 0.03 0.06 0.00 1.97 2.46 0.00 0.00 2.72 2.26 0.00 -0.30 1.00
Interest 0.51 0.30 0.28 0.32 0.25 0.29 0.47 0.41 0.23 0.59 0.55 0.69 0.63
Depreciation 0.20 0.20 0.20 0.20 0.20 0.17 0.05 0.20 0.53 0.20 0.21 0.21 0.35
Profit before tax 2.15 3.45 3.55 3.16 4.61 4.92 5.01 4.96 2.18 4.85 5.23 4.95 3.20
Tax % 22.33% 25.22% 25.07% 16.46% 14.75% 15.24% 16.97% 15.12% 30.73% 14.43% 13.38% 10.10% 6.56%
1.67 2.57 2.66 2.64 3.93 4.17 4.16 4.21 1.50 4.15 4.53 4.45 2.99
EPS in Rs 0.09 0.15 0.15 0.15 0.17 0.18 0.18 0.19 0.07 0.18 0.19 0.18 0.12
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
32 39 42 44 56 56 60 61 65 67 95 120
30 34 37 42 52 52 53 56 61 54 84 106
Operating Profit 2 4 5 2 4 3 7 5 5 12 10 14
OPM % 6% 11% 11% 5% 7% 6% 11% 9% 7% 19% 11% 12%
0 0 0 1 1 1 0 1 3 4 9 8
Interest 0 0 1 1 1 1 1 1 1 1 2 2
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 1 3 3 1 3 3 5 5 6 15 17 18
Tax % 23% 23% 13% 42% 26% 27% 20% 23% 24% 20% 18% 12%
1 2 3 1 2 2 4 4 5 12 14 16
EPS in Rs 0.03 0.12 0.14 0.04 0.12 0.10 0.21 0.21 0.26 0.52 0.62 0.66
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 15%
3 Years: 23%
TTM: 27%
Compounded Profit Growth
10 Years: 22%
5 Years: 31%
3 Years: 54%
TTM: 17%
Stock Price CAGR
10 Years: 5%
5 Years: 12%
3 Years: 15%
1 Year: -20%
Return on Equity
10 Years: 8%
5 Years: 8%
3 Years: 8%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 13 13 13 13 13 13 13 13 18 23 23 24
Reserves 13 16 18 19 21 23 27 31 61 148 162 194
4 2 4 2 5 5 7 10 1 1 1 23
10 11 14 16 13 16 12 14 16 34 32 33
Total Liabilities 39 42 49 50 52 57 59 68 96 205 218 274
15 15 16 16 16 15 14 14 15 16 20 22
CWIP 0 0 0 0 0 0 0 0 0 1 3 5
Investments 7 7 7 7 7 7 7 7 8 8 8 8
18 19 26 28 29 35 38 48 73 180 188 239
Total Assets 39 42 49 50 52 57 59 68 96 205 218 274

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 3 -0 3 2 -2 -1 7 -14 -33 -10 -40
-0 -1 -1 -1 -1 -0 -0 -1 -1 1 3 2
0 -2 1 -2 1 -0 2 2 21 79 2 35
Net Cash Flow 0 0 -0 0 2 -2 0 7 6 47 -5 -3
Free Cash Flow -0 2 -1 2 1 -2 -2 6 -17 -36 -15 -46
CFO/OP 26% 89% 13% 190% 55% -52% 1% 144% -315% -260% -92% -269%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 71 66 90 87 68 41 55 67 49 74 46 102
Inventory Days 23 47 43 31 57 78 50 72 133 148 133 174
Days Payable 121 114 139 161 88 86 59 72 58 133 58 65
Cash Conversion Cycle -27 -0 -7 -43 38 34 46 67 125 90 120 210
Working Capital Days 48 54 74 75 56 87 107 87 234 466 395 407
ROCE % 5% 12% 12% 6% 10% 8% 14% 12% 11% 13% 11% 10%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Employees
Numbers

Log in to view insights

Please log in to see hidden values.

Login
Trade Receivables Turnover Ratio
Ratio
Actual Production Volume
TPA
Installed Capacity
TPA
WHO-GMP Approved Products
Numbers

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
23.38% 23.61% 23.61% 18.41% 18.41% 18.41% 18.41% 18.41% 19.82% 23.62% 23.62% 23.63%
76.62% 76.39% 76.39% 81.58% 81.57% 81.59% 81.58% 81.58% 80.17% 76.38% 76.39% 76.36%
No. of Shareholders 52,98150,98869,72383,99687,82090,23692,50692,32691,18390,32086,30684,133

Documents

Announcements

Annual reports

Right Issue